We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal court has placed a temporary sales ban on Indian drugmaker Dr. Reddy’s Laboratories’ generic form of heartburn drug Nexium in the U.S. Read More
The majority of the Senate Committee on Health, Education, Labor and Pensions, from both sides of the aisle, supported Robert Califf’s nomination as the next FDA commissioner during a two-hour confirmation hearing Nov. 17. Read More
Biosimilars experts concluded that fostering the nascent industry would require many of the same elements that originally nurtured the generics industry: educational efforts, regulatory and patent changes, and most importantly, patience. Read More
Pfizer and Allergan announced Monday they have struck an agreement on their rumored merger, joining forces in a massive $160 billion deal that would create the world’s largest drugmaker and combine brand names such as Botox, Lipitor and Viagra. Read More
Two high-profile drugmakers have entered settlement agreements with federal and state justice departments over kickback allegations for prescribing practices. Read More
The FDA gave a thumbs up Monday to BioThrax to prevent anthrax following suspected or confirmed exposure in conjunction with recommended antibiotic treatment. Read More
An international aid group has negotiated a multi-year licensing agreement with Bristol-Myers Squibb to produce generic hepatitis C medicines in many developing nations. Read More